Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Avoid Sun Pharma, says Ashwani Gujral
Description
In an interview to CNBC-TV18, market expert Ashwani Gujral and Dipan Mehta Member of BSE & NSE, shared their reading and outlook on specific stocks and sectors.
More from User
03:06
Auto Expo 2020: Here's a look at MG Motor India's future ready portfolio
CNBC-TV18
02:30
Here’s what restauranteurs make of Mumbai 24x7
CNBC-TV18
04:15
Omar Abdullah's sister moves Supreme Court challenging his detention under the Public Safety Act
CNBC-TV18
04:02
Totally false that ousted CEO Neumann left with $1 Bn, says WeWork's executive chairman Marcelo Claure
CNBC-TV18
02:44
Indian ride hailing app Ola has rolled out its service in London
CNBC-TV18
02:35
London High Court to hear Mallya extradition case from tomorrow
CNBC-TV18
Related Videos
24:56
Avoid Sun Pharma and SPARC, says Ashwani Gujral
CNBC-TV18
25:38
Buy JSPL, HPCL & Sun TV, says stock analyst Ashwani Gujral
CNBC-TV18
02:38
Buy Sun Pharma, Idea, sell Wipro, RIL: Ashwani Gujral
ET NOW
01:11
Buy Cipla, Sun Pharma, Sell Tata Steel : Ashwani Gujral
ET NOW
23:19
Exit ADAG group stocks, says Ashwani Gujral
CNBC-TV18
25:17
Buy Avenue Supermarts & sell Bank of Baroda, Biocon, says market expert Ashwani Gujral
CNBC-TV18